Skip to content
Profiles

Taleen Hanania, PhD

PsychoGenics
Paramus, New Jersey
Chief Commercial Officer

Taleen Hanania, PhD, is Chief Commercial Officer at PsychoGenics. PsychoGenics leads CMT rodent model phenotyping and therapeutic screening for CMTA and third parties. Her work includes a standardized behavioral test battery across CMT mouse and rat models and biomarker analysis of neurofilament light chain (NfL) in plasma and CSF. Studies are conducted in a blinded, rigorous manner with the goal of advancing screened treatments into the clinic.

Taleen Hanania, PhD, in a red top with silver earrings and a pendant, smiles warmly against a dark gray studio backdrop.

Joined

2014

Therapy Type

All/Most therapy types and approaches specifically including small molecule; antibodies; ASOs; AAVs; and cell therapies

CMT1A, CMT2A and CMT2E